MYXREDLIN (Insulin Human) in 0.9% Sodium Chloride Injection

Myxredlin Insulin human in 0.9% sodium chloride, 100 units per 100 mL

Is your IV insulin ready when and where you need it? The first FDA-approved ready-to-use insulin infusion—MYXREDLIN—is ready to scan and hang.

Request More Information Options & Specifications

Explore this Product

Overview

Indication and Select Important Risk Information

MYXREDLIN is a short-acting human insulin indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.

Contraindications

During episodes of hypoglycemia
Hypersensitivity to insulin human or any of the excipients in MYXREDLIN

Please see the accompanying full Indication(s) and Important Risk Information and full Prescribing Information.

Available When and Where You Need It

A ready-to-use IV infusion helps reduce patient wait time for high-alert insulin. MYXREDLIN is ready to scan and hang.

Healthcare professional in scrubs, hairnet and surgical mask

MYXREDLIN Helps Support Safety

MYXREDLIN helps support safety with:

Opportunity to reduce medication errors associated with compounding^1,2
Consistent, reliable concentration of a commercially prepared insulin infusion¹
On-bag barcoding to help verify patient-medication association

Myxredlin 100 units per 100 ml insulin human premix injection

Reducing Risk in Insulin Therapy

In a review of preventable adverse drug events associated with inpatient injectable medications,* insulin had the highest probability for a preventable adverse drug event.³
IV insulin is ranked #1 for high-alert drugs among pharmacists and nurses.⁴
ISMP and ASHP guidelines recommend use of a commercially-prepared product instead of compounding as a risk-reduction strategy for high-alert medications.^1,2
When implemented alongside existing hospital best practices, MYXREDLIN can help reduce errors that may result from compounding practices.^1,2

Managing Efficiency with MYXREDLIN

MYXREDLIN can help:

Streamline insulin production and delivery.
Reduce expired or unused insulin waste⁵ because there are no additional costs related to disposal of preservative-free MYXREDLIN compared with insulin vials containing m-cresol.
Reduce the risk of preventable adverse drug events associated with compounding errors^1,2 and pharmacy resources spent compounding.

Switching to MYXREDLIN (Insulin Human) in 0.9% Sodium Chloride Injection Can Help Deliver More Value

Approximately 24 hours per week is spent on IV insulin preparation, according to a survey of 90 hospitals nationwide.⁶MYXREDLIN can help streamline insulin production and delivery by reducing expired insulin waste⁵ and may help to reduce compounding errors^1,2 and pharmacy resources spent compounding.

It really only takes one bad outcome associated with compounding to change your mind about using a premix IV product like MYXREDLIN. But why would you wait for a compounding error? …Every facility doesn’t always have 24-hour pharmacy, or sometimes there’s a STAT order for insulin that needs to be filled. I do not like the idea of asking Nursing to compound on the floor, especially during an emergency. MYXREDLIN lets us keep IV insulin in the automated dispensing cabinet.

Tina Collins

Organization

PharmD, Director of Corporate Clinical Medication Safety, CHRISTUS Health

MYXREDLIN has had a positive impact on our operations. The nursing staff appreciates having IV insulin available 24/7 in the automated dispensing cabinet. Pharmacy staff has been freed up to focus on compounding other products that don’t have a commercially prepared option. We’ve even improved our disposal process since we don’t have to treat the empty bags as hazardous waste.

Tina Collins

Organization

PharmD, Director of Corporate Clinical Medication Safety, CHRISTUS Health

We have transitioned from a shelf life of 9 days with our normal compounding operation to now 2 years’ worth of stability with MYXREDLIN when refrigerated, and 30 days at room temperature. We were excited to introduce it across our entire system because it allows our teams to focus on compounding other non-commercially available products.

Neil Gilchrist

Organization

Chief Pharmacy Officer, UMass Memorial Medical Center

We have less waste and MYXREDLIN relieves a burden on the IV room. We feel the value MYXREDLIN delivers offsets any incremental unit price increase, especially when you calculate the potential risk reduction… MYXREDLIN frees up the IV room to compound patient-specific scripts, as opposed to having to batch a medication that’s commercially available. So, it gives back staff time that can be reallocated to tasks that require the same skills and may have a bigger impact on workflow and finances.

Tina Collins

Organization

PharmD, Director of Corporate Clinical Medication Safety, CHRISTUS Health

Features

Designed for Flexibility and Readiness

30-Day Room Temperature Storage

Store closer to the patient.
Help reduce pharmacy STAT production.
If needed, MYXREDLIN may be removed from the original carton and stored at room temperature up to 77°F (25°C) for up to 30 days.

24-Month Refrigerated Shelf Life

Help ensure IV insulin is available when needed, reducing the need for on-the-floor compounding practices.
Store MYXREDLIN in the refrigerator at 36°F – 46°F (2°C – 8°C) in the original carton to protect from light.

Order & Support

Learn More About MYXREDLIN (Insulin Human) in 0.9% Sodium Chloride Injection

Request More Information Options & Specifications

Ordering and Support Information for MYXREDLIN (Insulin Human) in 0.9% Sodium Chloride Injection

Get additional ordering, customer, technical, and medical support information for MYXREDLIN (Insulin Human) in 0.9% Sodium Chloride Injection by contacting Baxter using the links below.

U.S. Catalog

To buy this product or look for options and specs please visit U.S. Catalog.

U.S. Catalog

U.S. Support

For manuals and documentation, product training, technical support and services, submit repair and return requests or check order status for Hillrom, Allen Medical and Welch Allyn product please visit U.S. Support.

U.S. Support

U.S. Edu

For medical information or non-promotional education about our products or therapies, please visit U.S. Edu.

U.S. Edu

Plan Your Inventory

View our supply availability report on our Baxter Supply Resources page by clicking the link below.

Baxter Supply Resource

Contact Us

To find contact details and assistance for Baxter products, report an adverse event or report a product complaint, or any other inquiries, please visit our contact us page.

Resources

Resources for MYXREDLIN (Insulin Human) in 0.9% Sodium Chloride Injection

Brochure

Emergency Medical Services Brochure

Brochure

Ambulatory Surgery Center Brochure